Control of GATA-3 expression is crucial for initiating Th2 and Th1 responses (Maes et al., 2011), so GATA-3 is recognized as an excellent candidate for the management of allergic diseases (Malmhäll et al., 2007). The gene discussed is GATA3; the disease is allergic disease.